RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/279ED7AF462073AEDC412D7F8543C82CA74FE1AB3EEFD98CE5C0C05441ACA11EA2E6E1101B67EA858744D7B8EEF6283Bhttp://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/279ED7AF462073AEDC412D7F8543C82CA74FE1AB3EEFD98CE5C0C05441ACA11EA2E6E1101B67EA858744D7B8EEF6283Bhttp://www.w3.org/2000/01/rdf-schema#comment"CDO1 promoter methylation is involved in gene regulation and is a potential prognostic biomarker for BCR-free survival in prostate cancer (PC) patients following radical prostatectomy. Further studies are needed to validate CDO1 methylation assays and to evaluate the clinical utility of CDO1 methylation for the management of PCa"xsd:string
http://purl.uniprot.org/uniprot/#_0DF2DDF3276E7ADE8FA43D276AFD764A6FFB0D448EAF741E971FBE1CEEEA52DEB83963F1F269EE117AD509A51A9DBC52http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/279ED7AF462073AEDC412D7F8543C82CA74FE1AB3EEFD98CE5C0C05441ACA11EA2E6E1101B67EA858744D7B8EEF6283B
http://purl.uniprot.org/uniprot/Q16878http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/279ED7AF462073AEDC412D7F8543C82CA74FE1AB3EEFD98CE5C0C05441ACA11EA2E6E1101B67EA858744D7B8EEF6283B
http://purl.uniprot.org/uniprot/#_Q16878-mappedCitation-27689475http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/279ED7AF462073AEDC412D7F8543C82CA74FE1AB3EEFD98CE5C0C05441ACA11EA2E6E1101B67EA858744D7B8EEF6283B